Press release
Global Gastrointestinal Drugs Market Competition By Players With Rising Growth: Janssen Biotech, Inc., Bayer AG, Sanofi, AstraZeneca, Allergan Plc and GlaxoSmithKline
ResearchMoz
Global Gastrointestinal Drugs Market
Gastro esophageal reflux disease (GERD), inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS) are types of gastrointestinal disease. gastro esophageal reflux disease (GERD) is a chronic gastric illness that arises when acidic juices in the stomach come back up into the esophagus from stomach, this can leads to irritation of esophagus and causes symptoms like heartburn, gas, etc. Inflammatory bowel disease is a group of chronic inflammation of small and large intestine. Ulcerative Colitis and Crohns disease are the two major types of inflammatory bowel disease. Irritable bowel syndrome (IBS) is a chronic condition that affects the colon (large intestine). Diarrhea, constipation, abdominal pain, cramping are the common symptoms of irritable bowel disease.
The market overview section of the report comprises qualitative analysis of the overall gastrointestinal drugs market considering the factors determining the market dynamics such as drivers, restraints and opportunities, along with Porters five force analysis and market attractiveness analysis. In addition, such as market opportunity analysis for the drug class, route of administration, drug class, distribution channel, and key industry developments has also been provided. Key industry developments include the major events occurred in past 4-5 years and are expected to occur during the forecast period which are likely to affect the market dynamics.
To Get Sample Copy of Report visit @ https://www.researchmoz.us/enquiry.php?type=S&repid=1038220
Global Gastrointestinal Drugs Market: Segmentation
The global gastrointestinal drugs market has been segmented on the basis of drug class, route of administration, drug class, distribution channel. On the basis of drug class the global gastrointestinal drugs market is segmented into acid neutralizers, antidiarrheal and laxatives, antiemetic and antinauseants, anti-inflammatory drugs, biologics and others including antispasmodic etc. The acid neutralizer segment is again segmented as antacids, H2 antagonists and Proton pump inhibitors. On the basis of route of administration, the global gastrointestinal drugs market has been segmented into three types such as, oral, parenteral and rectal.
Based on disorder type, the global gastrointestinal drugs market is segmented into gastro esophageal reflux disease, inflammatory bowel disease and Irritable bowel syndrome. On the basis of distribution channel, the global gastrointestinal drugs market is segmented as hospital pharmacies, retail pharmacies and online pharmacies.
The market for these drug class, route of administration, disorder type, and distribution channel has been extensively analyzed on the basis of factors such as usage pattern, sales revenue, and geographic presence and product developments. The market size and forecast in terms of revenue (US$ million), for each of these segments, and the sub-segments have been provided for the period 2014 to 2024, considering 2015 as the base year. The report also provides the compounded annual growth rate (CAGR) for each segment for the forecast period 2016 to 2024.
Browse TOC @ https://www.researchmoz.us/gastrointestinal-drugs-market-global-industry-analysis-size-share-growth-trends-and-forecast-2016-2024-report.html/toc
Geographically, the gastrointestinal drugs market has been classified into five segments, namely, North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. The market size forecast for each region has been provided for the period 2014 to 2024, in terms of drug class, route of administration, disorder type, and distribution channel, along with the CAGR (%) for the forecast period 2016 to 2024.
Global Gastrointestinal Drugs Market: Competitive Analysis
The report also provides a section on the competitive landscape, wherein the market share analysis of leading players in the global gastrointestinal drugs market, in terms of percentage share in 2016 (estimated) has been discussed. A list of recommendations has also been included for new entrants as well as existing market players to help them establish a strong presence in the market and increase their market share.
The report concludes with the profiles of major players in the global gastrointestinal drugs market such as Takeda pharmaceutical, Valeant Pharmaceuticals International, Inc., Janssen Biotech, Inc., Bayer AG, Sanofi, AstraZeneca, Allergan Plc, GlaxoSmithKline, Abbott Laboratories, Boehringer Ingelheim GmbH and Allergan Plc., among others. The major market players are evaluated on various parameters such as company overview, financial overview, product portfolio, business strategies and recent developments.
The global gastrointestinal drugs market is segmented as follows:
By Drug Class
Acid Neutralizers
Antacids
H2 antagonists
Proton pump inhibitors
Antidiarrheal and Laxatives
Antiemetic and Antinauseants
Anti-inflammatory drugs
Biologics
Others (Antispasmodic etc.)
By Route of Administration
Oral
Parenteral
Rectal
By Disorder Type
Gastro Esophageal Reflux Disease
Inflammatory Bowel Disease
Irritable Bowel Syndrome
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Spain
Rest of Europe
Asia Pacific
China
India
Japan
Australia & New Zealand
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Southern Global
Middle East & Africa
GCC countries
South Africa
Rest of Middle East & Africa
About ResearchMoz
ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
Mr. Nachiket
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Email: sales@researchmoz.us
Website @ http://www.researchmoz.us/
Tel: 866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-621-2074
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
Follow us on Blogger @ http://summaryofmarketresearchreports.blogspot.in/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Gastrointestinal Drugs Market Competition By Players With Rising Growth: Janssen Biotech, Inc., Bayer AG, Sanofi, AstraZeneca, Allergan Plc and GlaxoSmithKline here
News-ID: 1559009 • Views: …
More Releases for Gastro
Gastro-Esophageal Junction Neuroendocrine Tumor Market to Reach USD 940 Million …
Gastro-esophageal junction neuroendocrine tumors (GEJ-NETs) are rare malignancies that arise at the junction of the esophagus and stomach. These tumors originate from neuroendocrine cells, which secrete hormones, and are often characterized by aggressive growth patterns, delayed diagnosis, and high recurrence rates. Although rare compared to gastric or esophageal adenocarcinomas, GEJ-NETs pose significant clinical challenges due to limited awareness and treatment complexities.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71157
With…
Global Gastro Esophageal Reflux Disease (GERD) Drug Market: An In-Depth Analysis
The global Gastroesophageal Reflux Disease (GERD) therapeutics market was valued at approximately USD 5.29 billion in 2023. Projections suggest it will reach around USD 6 billion by 2032, reflecting a compound annual growth rate (CAGR) of approximately 1.76% from 2024 to 2032.
Global Gastro Esophageal Reflux Disease (GERD) Drug Market Overview
The Global Gastroesophageal Reflux Disease (GERD) Drug Market is experiencing steady growth, driven by the increasing prevalence of GERD…
Nutri Gastro Catering San Francisco - Elevating Culinary Experiences in the Hear …
San Francisco, CA - Nutri Gastro, a premier catering service based in San Francisco, is redefining the culinary landscape of the Bay Area with its innovative approach to corporate and event catering. Located at 1661 Tennessee St Unit 2K, Nutri Gastro is rapidly becoming the go-to destination for those seeking unmatched dining experiences infused with flavor, creativity, and health-conscious choices.
At Nutri Gastro, we understand that every event is unique, and…
Gastro-Intestinal Bleeding Clinical Trials | A Drug Pipeline Analysis Report 202 …
(Nevada, Las Vegas) United States, Gastro Intestinal Bleeding Pipeline Insight, 2023" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Gastro-Intestinal Bleeding market. A detailed picture of the Gastro-Intestinal Bleeding pipeline landscape is provided, which includes the disease overview and Gastro Intestinal Bleeding treatment guidelines. The assessment part of the report embraces in-depth Gastro Intestinal Bleeding commercial assessment and clinical assessment of the…
Global Gastro Esophageal Reflux Disease Drug and Devices Sales Market Report 201 …
Qyresearchreports include new market research report "Global Gastro Esophageal Reflux Disease Drug and Devices Sales Market Report 2017" to its huge collection of research reports.
The global Gastro Esophageal Reflux Disease Drug and Devices market has been methodically defined, evaluated, and forecasted on the basis of multiple factors such as segmentation type, geography, drivers and restraints, business opportunities and trends, and competitive landscape. All segments studied in the report have been…
Gastro-esophageal Reflux Disease (GERD)
Many people experience gastroesophageal reflux. This is actually normal, especially after eating a large meal. But when it happens too often, like more than twice in a week, it becomes known as
gastro-esophageal reflux disease or GERD. Also, it may be possible that you hear or read gastro acid reflux, acid reflux or simply acidity. These are all synonyms.
GERD is a condition wherein stomach contents flow back up into the…
